Kunio Suzuki
Directeur/Bestuurslid bij Banyu Pharmaceutical Co. Ltd.
Profiel
Kunio Suzuki is currently a Director at Banyu Pharmaceutical Co. Ltd.
and a Member-Supervisory Board at REGiMMUNE Corp.
He obtained his undergraduate and graduate degrees from Nagoya University and his doctorate from the University of Shizuoka.
Actieve functies van Kunio Suzuki
| Bedrijven | Functie | Begin |
|---|---|---|
Banyu Pharmaceutical Co. Ltd.
 Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan. | Directeur/Bestuurslid | 15-07-2009 |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Directeur/Bestuurslid | - |
Opleiding van Kunio Suzuki
| Nagoya University | Graduate Degree |
| University of Shizuoka | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Banyu Pharmaceutical Co. Ltd.
Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan. | Health Technology |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
